Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |